Lipocine Inc. Email Format

Pharmaceutical ManufacturingUtah, United States11-50 Employees

Lipocine Inc. is a clinical-stage biopharmaceutical company based in Salt Lake City, Utah, pursuing therapies administered orally through its proprietary lipid-based delivery platform, LIP’RAL®. The platform aims to enable effective oral delivery of challenging molecules, with a focus on improving bioavailability and patient adherence for metabolic, endocrine, and central nervous system disorders. The firm emphasizes a capital-efficient development path supported by a 505(b)(2) regulatory strategy and a global partnerships approach.

Lipocine’s portfolio includes TLANDO®, an FDA-approved oral testosterone therapy, along with a pipeline of clinical-stage programs addressing postpartum depression, liver disease (NASH and cirrhosis), obesity, and preterm birth prevention. Founded in 1997, the company remains headquartered in Salt Lake City. In 2024 Lipocine announced a supply and distribution agreement with Pharmalink Drug Store to commercialize TLANDO in GCC countries.

Sign up for free to view info

Company overview Employee directory